Back to results
CompletedPhase 2

UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study

NCT07163624

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The United Bio-Technology (Hengqin) Co., Ltd.

Zhuhai, Guangdong, China

View on ClinicalTrials.gov
UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study — TrialFind